Allopurinol - from gout to schizophrenia?

Nissen, Lisa (2007) Allopurinol - from gout to schizophrenia?. Australian Pharmacist, 26 8: 618-618.


Author Nissen, Lisa
Title Allopurinol - from gout to schizophrenia?
Journal name Australian Pharmacist  (ERA 2012 Listed)    (ERA 2010 Rank C)   Check publisher's open access policy
Publication date 2007-08
Year available 2007
Volume number 26
Issue number 8
ISSN 0728-4632
Start page 618
End page 618
Total pages 1
Place of publication Curtin, A.C.T.
Publisher Pharmaceutical Society of Australia
Collection year 2008
Language eng
Subject CX
1115 Pharmacology and Pharmaceutical Sciences
Abstract Recent research has led to a purinergic hypothesis of schizophrenia. It is postulated that increased adenosinergic transmission reduces the affinity of dopamine agonists for dopamine receptors. Allopurinol may increase circulating pools of adenosine and as such may ultimately have antipsychotic and anxiolytic effects. (non- author abstract)
Keyword Allopurinol, pharmacology
Models, Biological
Schizophrenia, etiology
Q-Index Code CX

 
Versions
Version Filter Type
Citation counts: Google Scholar Search Google Scholar
Access Statistics: 191 Abstract Views  -  Detailed Statistics
Created: Mon, 01 Sep 2008, 11:27:15 EST by Linda Mclean on behalf of Marketing, Outreach and Corporate Services